When does the Mounjaro injection start taking effect and how many kilograms can one lose

Mounjaro (tirzepatide) injections for weight loss have recently gained significant attention as a treatment option due to their role in supporting weight loss and reducing appetite, in addition to their use in managing type 2 diabetes. Their effectiveness is attributed to the active ingredient tirzepatide, which acts on hormones involved in regulating appetite and blood sugar levels. This helps increase feelings of fullness and reduce food intake.But when does Mounjaro start working? How many kilograms can you expect to lose? Does it effectively help combat obesity? And what are its potential benefits and side effects?In this article on Dalili Medical, we explore how Mounjaro injections work, when results typically become noticeable, the expected amount of weight loss, recommended dosages, and how to use them. We also cover the most important potential side effects, contraindications, and precautions to help ensure safe use under medical supervision.

1. What Are Mounjaro Injections for Weight Loss?

Mounjaro injections contain the active ingredient tirzepatide, which activates GIP and GLP-1 hormone receptors. This helps regulate blood sugar levels, reduce appetite, and increase feelings of fullness, thereby supporting weight loss.

2. Are Mounjaro Injections Used Only for Weight Loss?

No. Mounjaro was initially developed to help manage type 2 diabetes. In addition, tirzepatide has received medical approval for chronic weight management in individuals who meet the relevant medical criteria in certain countries.

3. How Often Should Mounjaro Injections Be Used?

Mounjaro is administered once weekly, on the same day each week. It is injected under the skin in one of the recommended areas: the abdomen, thigh, or back of the upper arm.

4. Is It Necessary to Follow a Diet While Using Mounjaro?

Yes. Following a healthy, balanced, reduced-calorie diet is recommended, along with regular physical activity. Combining treatment with healthy eating habits and exercise can help improve weight-loss results and maintain them over time.

5. Can Mounjaro Be Used by People Without Diabetes?

Yes. The active ingredient tirzepatide may be used for weight management in people with obesity or overweight accompanied by weight-related health conditions, even if they do not have diabetes. This depends on the medical approvals in each country and requires a doctor's assessment before starting treatment.

6. Do Mounjaro Injections Cause Loose Skin?

Rapid or significant weight loss while using Mounjaro may lead to loose or sagging skin, particularly around the abdomen, arms, and thighs. This depends on several factors, including the amount of weight lost, skin elasticity, and age, rather than being a direct effect of the injections alone.

7. Do Mounjaro Injections Cause Hair Loss?

Some people may notice increased hair shedding during treatment. This may be associated with rapid weight loss, reduced food intake, or deficiencies in essential nutrients needed for healthy hair growth.

8. What Happens If You Miss a Mounjaro Dose?

A missed dose can be administered within 4 days (96 hours) of the scheduled time. If more than 4 days have passed, skip the missed dose and take the next dose on your regular scheduled day. Do not take a double dose to make up for the missed injection.

9. Can Mounjaro Injections Be Stopped After Reaching the Ideal Weight?

Treatment can be discontinued after consulting a doctor. However, appetite may increase, and some people may regain part of the weight they lost after stopping the injections. Therefore, it is recommended to develop an appropriate weight-maintenance plan after completing treatment.

10. Do Mounjaro Injections Affect Menstrual Cycle Regularity?

Menstrual irregularities are not considered a well-established common side effect of Mounjaro injections. However, significant weight changes or dietary changes associated with treatment may affect hormonal balance and menstrual cycle regularity in some women.

11. Can Mounjaro Be Used with Other Weight-Loss Medications?

Combining Mounjaro with other weight-loss medications without medical supervision is not recommended, as this may increase the risk of side effects or drug interactions. You should consult your doctor before using any additional weight-loss treatment to assess its suitability and the safety of combining the medications.

12. Do Mounjaro Injections Affect Birth Control Pills?

Mounjaro may reduce the effectiveness of certain oral hormonal contraceptives because it slows gastric emptying, which may affect their absorption.

Therefore, the US prescribing information recommends using a non-oral contraceptive method or adding a barrier method, such as condoms, for 4 weeks after starting treatment and for 4 weeks after each dose increase.

13. Does Weight Return After Stopping Mounjaro Injections?

Yes. Some people may regain part of the weight they lost after stopping treatment, and their appetite may increase again. Therefore, it is advisable to discuss a treatment discontinuation plan with your doctor and continue following a balanced diet and engaging in regular physical activity to help maintain the results.

14. How Many Kilograms Can You Lose with Mounjaro Injections?

The amount of weight you can lose varies from person to person, depending on factors such as initial body weight, dosage, treatment duration, and individual response.

In the SURMOUNT-1 clinical trial, which lasted 72 weeks and included people with obesity or overweight without diabetes, the average weight loss was approximately:

16.1 kg with a weekly dose of 5 mg.
22.2 kg with a weekly dose of 10 mg.
23.6 kg with a weekly dose of 15 mg.

These figures represent average results observed in a clinical trial and are not guaranteed weight-loss amounts for every individual. Higher doses are also introduced gradually under medical supervision.

15. When Do Mounjaro Injections Start Working for Weight Loss?

Mounjaro may begin affecting appetite and blood sugar levels during the first few weeks of treatment. However, noticeable weight loss usually takes longer to occur.

The time required to see results varies depending on the dosage, individual response, initial body weight, and adherence to a healthy diet and regular physical activity. Therefore, there is no fixed timeline for achieving results that applies to everyone.

16. How Long Does the Effect of Mounjaro Injections Last?

Mounjaro is administered once weekly because its effects last for several days. However, its effects do not disappear suddenly after 7 days, as the amount of medication in the body gradually decreases.

Tirzepatide has a half-life of approximately 5 days, meaning that it may remain in the body for some time after the injection, although the duration of its effects can vary from person to person.

You should follow your prescribed weekly injection schedule and avoid changing the dosing regimen or discontinuing treatment without consulting your doctor.

What Are the Ingredients of Mounjaro Weight-Loss Injections?

Mounjaro injections, which are used to support weight loss, contain an active ingredient known as tirzepatide. This medication helps regulate appetite and blood sugar levels and supports weight reduction by acting on hormones responsible for hunger and satiety, thereby helping reduce food intake.

Ingredients of Mounjaro Weight-Loss Injections

Mounjaro injections contain two main types of ingredients:

1. Active Ingredient – Tirzepatide

Tirzepatide is the primary active ingredient in Mounjaro injections. It works by activating GIP and GLP-1 hormone receptors, which helps:

Reduce appetite and decrease feelings of hunger.
Slow gastric emptying, thereby prolonging feelings of fullness.
Improve blood sugar regulation.
Reduce food intake and support weight loss.

2. Inactive Ingredients (Excipients)

These ingredients are added to help maintain the stability and quality of the solution and regulate its pH. Ingredients found in some single-dose pens include:

Sodium Chloride.
Sodium Phosphate Dibasic Heptahydrate.
Water for Injection.
Hydrochloric Acid or Sodium Hydroxide, which may be used to adjust the pH when necessary.

What Are the Different Types of Mounjaro Injections?

Mounjaro injections are available in several strengths, depending on the amount of the active ingredient (tirzepatide) in each dose. The doctor determines the appropriate strength based on the patient's response to treatment and tolerance of the medication.

The injections are administered subcutaneously once weekly and are available in specially designed injection pens. Pen designs and administration methods may vary depending on the packaging and the market in which the medication is available.

The different Mounjaro strengths include:

1. Mounjaro 2.5 mg

This dose contains 2.5 mg of tirzepatide and is usually prescribed as the starting dose to help the body adjust to the medication and reduce the likelihood of side effects at the beginning of treatment.

2. Mounjaro 5 mg

This dose contains 5 mg of the active ingredient and is generally used after the initial dose, depending on the doctor's assessment. It helps enhance the medication's effects on appetite regulation and blood sugar control.

3. Mounjaro 7.5 mg

This dose contains 7.5 mg of tirzepatide and is considered an intermediate strength during dose escalation. The doctor may recommend it depending on the patient's response to previous doses.

4. Mounjaro 10 mg

This dose contains 10 mg of the active ingredient and is considered one of the higher Mounjaro strengths. Moving to this dose depends on the body's response to treatment and tolerance of previous doses.

5. Mounjaro 12.5 mg

This dose contains 12.5 mg of tirzepatide and represents an advanced stage of dose escalation. The doctor may prescribe it when a higher dose is needed, depending on the patient's medical condition.

6. Mounjaro 15 mg

This is the highest available Mounjaro dose, containing 15 mg of the active ingredient per dose. The doctor determines whether this strength is appropriate based on the patient's response to treatment and ability to tolerate the medication.

What Are the Uses of Mounjaro Injections?

Mounjaro injections contain the active ingredient tirzepatide and are used to help improve blood sugar control in people with type 2 diabetes.

They are also used to support weight loss in individuals with obesity or overweight accompanied by weight-related health conditions, depending on the medical approvals and regulatory authorizations in each country.

Indications for Using Mounjaro Injections

The main indications for using Mounjaro injections include:

1. Treatment of Type 2 Diabetes:

Mounjaro injections help lower blood sugar levels and improve glycemic control by stimulating insulin secretion when blood glucose levels are elevated and reducing the release of glucagon, thereby helping regulate blood glucose levels.

2. Supporting Weight Loss and Treating Obesity:

Mounjaro injections help reduce appetite and feelings of hunger. They also slow gastric emptying and increase feelings of fullness, which helps reduce food intake and promote weight loss.

3. Managing Overweight Accompanied by Health Conditions:

Tirzepatide may be used to support weight loss in people who are overweight and have related health conditions, such as high blood pressure or abnormal blood lipid levels, depending on local medical approvals.

4. Helping Maintain Weight After Weight Loss:

Mounjaro injections may help maintain appetite control and support long-term weight management after weight loss, particularly when used as part of a comprehensive treatment plan that includes a healthy diet and regular physical activity.

What Are the Recommended Mounjaro Dosages?

Mounjaro dosages vary depending on the purpose of treatment, the body's response, and the patient's tolerance of the medication. The injections are administered subcutaneously once weekly, with gradual dose increases according to the doctor's instructions.

First: Standard Adult Dosage for Type 2 Diabetes

The recommended Mounjaro dosage for treating type 2 diabetes is generally as follows:

Starting dose: 2.5 mg injected subcutaneously once weekly for 4 weeks.
Next dose: Increase to 5 mg once weekly after completing the first 4 weeks.
Dose escalation: The doctor may increase the dose by 2.5 mg after at least 4 weeks on the current dose if additional blood sugar control is needed.
Maximum dose: 15 mg injected subcutaneously once weekly.

It is important to note that the 2.5 mg dose is intended to initiate treatment and help the body adjust to the medication. It is not intended to provide the desired therapeutic level of blood sugar control.

Second: Standard Mounjaro Dosage for Weight Loss in Adults

The following doses may be used depending on the body's response to treatment and the doctor's assessment:

Starting dose: 2.5 mg injected subcutaneously once weekly for 4 weeks.
Next dose: 5 mg injected subcutaneously once weekly, starting from week 5.
Dose escalation: The dose may be increased by 2.5 mg after at least 4 weeks on the current dose, depending on treatment response and medication tolerance.
Maintenance doses: 5 mg, 10 mg, or 15 mg once weekly, depending on the patient's needs and the doctor's assessment.
Maximum dose: 15 mg injected subcutaneously once weekly.

Important Instructions When Using Mounjaro

Follow the prescribed dosage and never increase it on your own.
The weekly injection day can be changed if necessary, provided that at least 72 hours have passed between doses.
Inject the medication under the skin of the abdomen, thigh, or back of the upper arm.
It is preferable to maintain a consistent injection day every week to ensure regular treatment.
Do not combine Mounjaro with other medications containing tirzepatide or medications belonging to the GLP-1 receptor agonist class unless directed by your doctor.

How to Use Mounjaro Injections

You should consult your doctor before using Mounjaro injections to assess your medical condition, determine whether the medication is appropriate, and establish the correct dosage, particularly if you have chronic medical conditions or take other medications.

The most important instructions for using Mounjaro injections include:

Inject the medication under the skin using the designated injection pen.
Use the medication once weekly, at any time of the day, with or without food.
You may change your weekly injection day if necessary, provided that at least 72 hours have passed between doses.
Follow your doctor's prescribed dosage and do not increase or decrease it without medical advice.
The injection can be administered in the abdomen, thigh, or back of the upper arm.
It is recommended to rotate injection sites each time to avoid repeatedly injecting into the same spot.
Treatment usually starts with a low dose, which is gradually increased according to the body's response and tolerance.
Do not use the injection more than once a week.

Where Can Mounjaro Be Injected?

Mounjaro injections can be administered subcutaneously in three main areas:

1. Abdomen: The injection can be administered in the abdominal area, avoiding the area immediately surrounding the belly button.

2. Thigh: The injection can be administered into the front or outer area of the thigh.

3. Back of the Upper Arm: It is preferable for another person to administer the injection in this area to ensure proper access and accurate administration.

It is recommended to rotate the injection site weekly. You can continue using the same general area, provided that you choose a different injection spot each time.

Steps for Using the Mounjaro Injection Pen

The method of using a Mounjaro pen varies depending on its design. There are single-dose pens and multi-dose pens, such as the KwikPen. Therefore, it is important to follow the instructions provided with the specific pen you have.

First: Preparation Before the Injection

Wash your hands thoroughly with soap and water before starting.
Check the medication name, strength, and expiration date.
Inspect the solution to ensure that it is clear, colorless or slightly yellow, and free of particles or cloudiness.
Choose an appropriate injection site, clean the skin with an alcohol swab, and allow it to dry.

Second: Steps for Using the Multi-Dose KwikPen

Remove the outer pen cap.
Attach a new needle designed for the pen, making sure it is securely fitted.
Remove the outer needle cap and keep it, then remove the inner needle cap and discard it.
Prepare the pen according to the manufacturer's instructions by performing the priming step to ensure that the pen is ready for injection.
Turn the dose knob until it stops and the number 1 appears in the dose window, indicating that a full dose has been selected.
Insert the needle under the skin at the selected injection site, following the method described in the patient information leaflet.
Press and hold the dose knob until the dose indicator reaches zero, then wait for the period specified in the pen instructions.
Gently withdraw the needle from the skin.
Carefully replace the outer needle cap, remove the needle from the pen, and dispose of it in an approved sharps container.
Replace the pen cap and store the pen according to the manufacturer's storage instructions.

Important Notes When Using the Mounjaro Pen:

A new needle must be used for every injection with multi-dose pens.
Never share your Mounjaro pen with anyone else, even if the needle is changed.
The KwikPen contains four fixed weekly doses and should be discarded after all four doses have been used or 30 days after first use, according to the approved patient information leaflet.
Do not attempt to withdraw the remaining medication from the pen using a regular syringe to obtain an additional dose.
The injection steps for single-dose pens are different. They do not require attaching a separate needle or setting the dose in the same way as the KwikPen.

What Are the Common Side Effects of Mounjaro Injections?

Mounjaro injections contain the active ingredient tirzepatide and may cause several potential side effects. Most of these effects involve the digestive system, particularly at the beginning of treatment or following a dose increase.

The severity of these symptoms varies from person to person, and they may gradually improve as the body adjusts to the medication.

What Are the Side Effects of Mounjaro Injections?

The side effects of Mounjaro can be divided into common symptoms and less common but potentially more serious complications that require medical attention.

First: Common Side Effects

Some of the most common side effects experienced by Mounjaro users include:

1. Nausea: This is one of the most common side effects. It may occur during the initial stages of treatment or after increasing the dose and may be accompanied by stomach discomfort.

2. Vomiting: This may occur because of the medication's effect on stomach movement and delayed gastric emptying.

3. Diarrhea: Some users may experience more frequent bowel movements or changes in stool consistency, resulting in looser stools.

4. Constipation: The medication may affect digestive system movement, leading to difficulty passing stools or fewer bowel movements.

5. Abdominal Pain: Users may experience stomach cramps or abdominal discomfort of varying severity.

6. Loss of Appetite: The medication helps reduce hunger and the desire to eat, which is one of the effects that contributes to weight loss.

7. Bloating and Gas: Some people may experience abdominal fullness or increased gas.

8. Indigestion, Heartburn, and Belching: These digestive symptoms may occur because tirzepatide affects stomach movement and gastric emptying.

9. Fatigue and Tiredness: Some users may experience exhaustion or reduced energy levels, particularly when food intake decreases or dehydration occurs.

Second: Less Common and More Serious Side Effects

Mounjaro injections may be associated with certain health complications that require attention. The most important include:

1. Acute Pancreatitis:

This is a rare complication that may occur during treatment. It typically presents as severe, persistent pain in the upper abdomen, which may radiate to the back and may be accompanied by nausea and vomiting. If these symptoms occur, stop using the medication and seek urgent medical evaluation.

2. Gallbladder Problems:

Mounjaro may increase the risk of certain gallbladder problems, such as gallstones or gallbladder inflammation (cholecystitis). Symptoms may include pain in the upper-right abdomen, sometimes accompanied by nausea or fever.

3. Low Blood Sugar (Hypoglycemia):

Low blood sugar may occur, particularly when Mounjaro is used alongside insulin or certain other diabetes medications, such as sulfonylureas. Symptoms may include excessive sweating, shaking, dizziness, palpitations, and hunger.

4. Dehydration and Kidney Problems:

Severe or persistent vomiting and diarrhea may cause significant fluid loss, increasing the risk of dehydration and potentially affecting kidney function.

5. Severe Allergic Reactions:

Rare allergic reactions may occur, including severe skin rash or swelling of the face, lips, tongue, or throat. These reactions may be accompanied by difficulty breathing. This is a medical emergency that requires immediate medical attention.

6. Severe Gastrointestinal Disorders:

The medication may cause severe digestive problems in some people and may worsen delayed gastric emptying, particularly in individuals with severe gastrointestinal motility disorders.

7. Worsening of Diabetic Retinopathy:

Diabetic retinopathy may worsen in some patients who already have retinal problems, particularly when blood sugar levels decrease rapidly. These patients may require regular follow-up with an ophthalmologist.

When Should You Stop Using Mounjaro and Consult a Doctor?

You should stop using Mounjaro injections and seek urgent medical attention if you experience symptoms that may indicate serious complications, particularly if they are severe or sudden.

The most important warning signs include:

Severe and persistent abdominal pain: Particularly if the pain radiates to the back, as this may indicate acute pancreatitis.
Repeated or severe vomiting: Especially if you cannot keep fluids down, as this may cause dehydration and impaired kidney function.
Signs of a severe allergic reaction: Such as swelling of the face, lips, tongue, or throat, or difficulty breathing. This requires emergency medical intervention.
Severe abdominal pain accompanied by yellowing of the skin or eyes: This may indicate a problem with the gallbladder or bile ducts.
Symptoms of severe hypoglycemia: Such as confusion, seizures, or loss of consciousness, particularly in people using Mounjaro alongside insulin or certain other diabetes medications.

Do not wait for these symptoms to disappear on their own. Seek appropriate medical evaluation as soon as they occur.

Tips for Reducing the Side Effects of Mounjaro Injections

You can follow several recommendations to help reduce digestive disturbances and other symptoms associated with Mounjaro treatment. These include:

Eat smaller, more frequent meals throughout the day instead of consuming large meals.
Avoid fatty, fried, and high-fat foods, particularly during the initial stages of treatment.
Drink sufficient amounts of water and other fluids to reduce the risk of dehydration.
Eat slowly, chew your food thoroughly, and stop eating as soon as you feel full.
Avoid lying down immediately after eating, especially if you experience heartburn or acid reflux.
Follow your doctor's prescribed dosage and never increase it or take the next dose earlier than scheduled on your own.
Do not move to a higher dose until the recommended period has passed and your doctor has evaluated your condition.
Inform your doctor if nausea, vomiting, diarrhea, or constipation persists or interferes with your daily activities.

What Are the Contraindications of Mounjaro Weight-Loss Injections?

There are certain conditions in which Mounjaro injections are contraindicated, while other conditions require caution and medical evaluation before starting treatment or while using the medication.

The most important contraindications and precautions include:

1. Allergy to Tirzepatide:

Mounjaro injections must not be used by individuals who have previously experienced a severe allergic reaction to the active ingredient tirzepatide or any of the medication's components.

2. Personal or Family History of Medullary Thyroid Carcinoma:

According to the US prescribing information, Mounjaro is contraindicated in individuals with a personal or family history of medullary thyroid carcinoma (MTC), due to warnings concerning thyroid tumors observed in animal studies.

3. Multiple Endocrine Neoplasia Syndrome Type 2 (MEN2):

Having this condition is a contraindication to Mounjaro use under US prescribing information because of its association with an increased risk of medullary thyroid carcinoma.

4. Pregnancy:

Mounjaro is not recommended for weight-loss purposes during pregnancy. Anyone who becomes pregnant while using the medication should contact their doctor promptly to determine the appropriate course of action.

5. Breastfeeding:

Breastfeeding women should consult their doctor before using Mounjaro to assess the potential benefits and risks, particularly because information about the transfer of tirzepatide into breast milk and its effects on infants remains limited.

6. Severe Gastroparesis:

Mounjaro is not recommended for people with severe gastroparesis or serious gastric emptying disorders because the medication slows gastric emptying and may worsen digestive symptoms.

7. Previous History of Pancreatitis:

A previous episode of pancreatitis is not an absolute contraindication to Mounjaro use. However, it requires careful medical evaluation before starting treatment, along with monitoring for symptoms that may indicate recurrent inflammation.

8. Gallbladder Diseases:

People with gallstones or gallbladder inflammation should use caution and undergo medical monitoring because of the possibility of gallbladder-related complications during treatment.

9. Kidney Diseases:

Mounjaro can be used in some people with kidney disease following medical evaluation. However, attention should be paid to the risk of dehydration caused by vomiting or diarrhea, as fluid loss may worsen kidney function.

10. Diabetic Retinopathy:

People with diabetes who have diabetic retinopathy require regular follow-up with an ophthalmologist, particularly when blood sugar levels decrease rapidly, because certain retinal complications may worsen.

Best doctors سمنة ونحافة

featured